Idorsia Ltd. (IDRSF)
5.65
-0.10
(-1.74%)
USD |
OTCM |
May 29, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.435B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 203.8% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 5.001 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -1.114 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 97.99% |
Profile
| Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, and EUCAN. The company was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland. |
| URL | http://www.idorsia.com |
| Investor Relations URL | N/A |
| HQ State/Province | Basel-Landschaft (Basle Country) |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Jul. 30, 2026 |
| Last Earnings Release | Apr. 28, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, and EUCAN. The company was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland. |
| URL | http://www.idorsia.com |
| Investor Relations URL | N/A |
| HQ State/Province | Basel-Landschaft (Basle Country) |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Jul. 30, 2026 |
| Last Earnings Release | Apr. 28, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |